Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Larry Dillaha currently holds 19,079 shares of SCIELE PHARMA, INC. (SCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Larry Dillaha has been a net seller of SCRX stock. They have purchased $0 and sold $11.4M worth of shares.
Larry Dillaha's most recent insider trade was on Mar 5, 2014, when they sold 17,863 shares at $77.24 per share.
Larry Dillaha serves as Executive at SCIELE PHARMA, INC. (SCRX). They have executed 25 insider transactions totaling $11.4M over their tenure at the company.
Larry Dillaha holds the position of Executive at SCIELE PHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Larry Dillaha has shown a selling trading pattern, with $0 in total purchases and $11.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Larry Dillaha was on Mar 5, 2014, when they sold $7.1M worth of INSY shares. This transaction involved 97,789 shares at $72.65 per share.
Larry Dillaha currently owns 19,079 shares of SCIELE PHARMA, INC. (SCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Larry Dillaha's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Larry Dillaha has 25 Form 4 filings on record as an insider at SCIELE PHARMA, INC..
Set alerts for Larry Dillaha and 40,000+ other insiders.